To evaluate neuronal nitric oxide (NO) synthase (nNOS) phosphorylation, nNOS uncoupling, and oxidative stress in the penis and major pelvic ganglia (MPG), before and after the administration of the cAMP-dependent protein kinase A (PKA) agonist colforsin in a rat model of bilateral cavernous nerve injury (BCNI),which mimics nerve injury after prostatectomy.
Introduction
Erectile dysfunction (ED) is a major clinical complication associated with pelvic surgeries such as radical prostatectomy (RP). Successful sexual intercourse rates at 1 year after surgery have been reported to be between 15% and 87% [1] . As an intact autonomic nerve supply to the penis promotes the structural and functional health of the cavernosal tissue, cavernous nerve (CN) injury is a predominant cause of RPassociated ED [2] . At the cellular level, CN injury results in apoptosis of corporal smooth muscle and endothelium, upregulation of profibrotic cytokines, hypoxia, increased collagen synthesis, and fibrosis within the corpora cavernosa [3] [4] [5] [6] . Molecular conditions underlying these changes involve upregulation of the RhoA-ROCK pathway, dysregulation of growth factor expression, increased oxidative/nitrosative stress, and decreased neuronal nitric oxide (NO) synthase (nNOS) expression in the penile innervation [7] [8] [9] [10] [11] [12] .
nNOS-containing autonomic nerves are the principal sites in the penis for production of NO, the main mediator of penile erection [13] . In a rat model of CN injury, nNOS protein expression and activity in the penis and major pelvic ganglia (MPG) decrease in parallel with degeneration of nerve terminals [7, 14, 15] . Furthermore, it has been suggested that the absence of cavernosal cycling between the flaccid and erect state secondary to penile neuropathy results in further structural and functional damage to the corpora cavernosa [16] . Current ED treatments, such as phosphodiesterase type 5 inhibitors, are less effective in men with ED resulting from RP compared with the general population with ED [17, 18] ; therefore, other therapeutic strategies are needed to preserve the penis and MPG from structural and molecular changes during the period of neural recovery.
Post-translational modification of nNOS on Ser-1412 by protein kinase A (PKA)-mediated phosphorylation constitutes a major regulatory mechanism for NO generation in the penis and MPG [19] . Neuronal stimulation, presumably through the increase in intracellular calcium and adenylate cyclase activation, causes an increase in intracellular cAMP that activates PKA [20] , which phosphorylates nNOS at Ser-1412, stimulating nNOS catalytic activity [19] . This phosphomodification lasts longer than the neuronal calcium transient, thus contributing to both the initiation and maintenance phases of erection [19] . nNOS activity is also regulated by its functional dimerization. Under physiological conditions, NOSs are homodimeric enzymes that catalyse the conversion of L-arginine to NO [21] ; however, under pathological conditions resulting in a loss of the functional enzyme's dimerization, NOSs can transform into prooxidants, generating predominantly superoxide anion rather than NO ('NOS uncoupling') [22] .
The mechanism of ED and, specifically, the molecular basis for the nNOS defect in the neuropathic penis and penile innervation is unclear and requires further investigation. In accordance with the indispensable role of nNOS posttranslational activation in the erectile process, our hypothesis in the present study was that nNOS post-translational activation serves as a homeostatic mechanism that is altered in the context of penile neuropathy. We further hypothesized that preserving physiological nNOS function through cAMP/ PKA-mediated nNOS phosphorylation and proper nNOS coupling optimizes nNOS bioactivity that counteracts neuropathic oxidative stress in the penis and penile innervation. We therefore studied whether the PKA activator colforsin is capable of improving erectile function in a rat model of bilateral CN injury (BCNI), and if so, whether the improvement is attributable to preserving optimal nNOS phosphorylation and coupled function, and limiting oxidative stress in the erectile tissue and penile innervation.
Materials and Methods

Animals and Study Design
Adult male Sprague-Dawley rats (325-350 g; Charles River Breeding Laboratories, Wilmington, MA, USA) were used. The rats were randomly divided into four groups (n = 8-10/group): sham-operated (sham) + vehicle (saline); sham + colforsin (Abcam, Cambridge, MA, USA, 0.1 mg/kg/day); BCNI + vehicle; and BCNI + colforsin (0.1 mg/kg/day). This dose of colforsin was chosen based on our dose-response pilot study, which showed that 0.1 mg colforsin per day is the most effective dose in preserving erectile function (data not shown). Colforsin and vehicle were administered i.p. 2 h before BCNI, and 24 and 48 h after BCNI. Twenty-four hours after the last treatment, erectile function in response to electrical stimulation of the CN was evaluated, and 10 min after the termination of CN electrical stimulation, the penis and MPG were collected for molecular investigations. We used a 1-day washout period in order to exclude the direct calcium-dependent effect of PKA activation on corporal smooth muscle [4] [5] [6] 23, 24] . We chose to perform this study 3 days after BCNI in order to assess early molecular changes associated with CN injury devoid of penile fibrotic changes, which occur as early as 1 week after BCNI [25] .
Cavernous Nerve Injury
To perform BCNI on anaesthetized rats (2.5% isoflurane with 1 L/min O 2 flow), CNs were identified bilaterally via a midline lower abdominal incision, and crushed 2-3 mm distal to the MPG [26] . BCNI was induced by crushing the CNs with an ultra-fine haemostat (Fine Science Tools, Foster City, CA, USA) at a constant 'two-click' pressure for 2 min per side. Sham surgeries were completed by exposing the CNs but not manipulating them [27] .
Penile Erection Studies
Intracavernosal pressure (ICP) was measured in anaesthetized (100 mg/kg ketamine/5 mg/kg xylazine) rats [27] . The electrode was attached to a Grass Instruments S48 stimulator. The stimulation parameters were 16 Hz at 1V and 4V with monophasic, square-wave duration of 5 ms. The duration of electrical stimulation of CN was 1 min. Response parameters were recorded using data acquisition (DI-190, Dataq Instruments, Akron, OH, USA), and results were analysed using MATLAB software (Mathworks, Natick, MA, USA). Maximum ICP (maximum pressure that is reached during CN electrical stimulation) and total ICP (ICP area under the curve, indicating the ICP response for the duration of CN electrical stimulation) were expressed per mean arterial pressure (MAP) as a difference from baseline. 
Western Blot Analysis
Frozen tissue was homogenized (penis) or sonicated (MPG) [19, 28] . nNOS was partially purified from penile homogenates by affinity binding to 2 0 ,5 0 -ADP Sepharose [28] . Partially purified nNOS samples or penile and MPG homogenates were resolved on 7.5% or 4-20% Tris gels and transferred to polyvinylidene difluoride membrane. Membranes with partially purified nNOS were probed with anti-phospho (P)-nNOS (Ser-1412 and Ser-847) antibodies (polyclonal rabbit, kindly provided by Dr Solomon Snyder at the Johns Hopkins University, Baltimore, MD, USA, and Abcam, Cambridge, MA, USA, respectively) at 1:6000 and 1:1000 dilutions, respectively (for P-nNOS analyses), anti-nNOS antibody (polyclonal rabbit; Cell Signaling Technology, Beverly, MA, USA) at 1:1000 dilution (for nNOS uncoupling analyses), and protein inhibitor of nNOS (PIN) antibody (monoclonal mouse; BD Transduction Laboratories, San Diego, CA, USA) at 1:500 dilution (for PIN binding to nNOS) [29, 30] . After probing for P-nNOS (Ser-1412 and Ser-847) or PIN, these membranes were stripped and probed with anti-nNOS antibody (polyclonal rabbit, Solomon Snyder MD, Johns Hopkins University, Baltimore, MD, USA) at 1:9000 dilution. P-nNOS (Ser-1412 and Ser-847) and PIN densities were normalized relative to those of nNOS in partially purified samples. For immunoblot analyses of dimeric and monomeric forms of nNOS, purified samples (penis) or homogenates (MPG) in Laemmli buffer were not heated, and the temperature of the gel was maintained below 15°C during electrophoresis [31] . For Western blot analysis of total nNOS (polyclonal rabbit antibody; Cell Signaling Technology, 1:1000 dilution), PKA catalytic subunit a (PKA-Ca; polyclonal rabbit antibody, Cell Signaling Technology, 1:500 dilution), gp91 phox (monoclonal mouse antibody, BD Transduction Laboratories, 1:1000 dilution) and cleaved caspase 3 (polyclonal rabbit antibody, Cell Signaling Technology, 1:1000 dilution), a separate set of homogenates (70-100 lg) was used without purification and standardized to b-actin (monoclonal mouse antibody, Sigma Chemical, St. Louis, MO, USA, 1:4000 dilution). Band densities were quantified using NIH IMAGE J 1.29. The ratio was determined in terms of arbitrary units and expressed relative to the ratio for vehicle-treated sham rats. nNOS uncoupling was represented inversely as a ratio of nNOS dimers to nNOS monomers. To verify that b-actin expression was not affected by BCNI or colforsin treatment, the density of a set of samples was standardized per total proteins (Ponceau S staining). Ratios did not differ from those obtained using b-actin for standardization (data not shown).
In vivo Reactive Oxygen Species Production
In vivo H 2 O 2 and superoxide were measured in the penis via microdialysis on anaesthetized rats [32, 33] . The penis was freed of skin and fascia, and a linear microdialysis probe (Bioanalytical Systems, Inc., West Lafayette, IN, USA) with a 20-kDa maximal pore size was inserted into the shaft of the penis. Microdialysis probes were perfused with saline containing 100 lM Amplex Ultrared (Molecular Probes, Eugene, OR, USA) and 1.0 U/mL horseradish peroxidase (HRP; Sigma Aldrich, St. Louis, MO, USA) at 1.0 lL/min with a microdialysis pump (Harvard Apparatus, Holliston, MA, USA). Amplex Ultrared is a fluorogenic substrate, which in the presence of HRP reacts with H 2 O 2 to produce the highly fluorescent resorufin [34, 35] . Three 15-min replicate samples were collected, and fluorescence of the dialysate was measured in a fluorometer (BioRad, Hercules, CA, USA) at 510 nm Ex/590 nm Em. Then, 10 U/mL superoxide dismutase (SOD; Sigma Aldrich) was added to the perfusate, allowing conversion of superoxide that crosses over the microdialysis membrane into H 2 O 2 , which then stimulates the conversion of Amplex Ultrared to resorufin by HRP [36] . Three 15-min replicate samples were collected, from which fluorescence was measured. Following measurements, penile tissue was harvested, and stored at -80°C until analysis.
Statistical Analysis
Data were expressed as means AE SEM. Statistical analyses were performed using one-way ANOVA, followed by Tukey's multiple comparison test for ICP analyses and in vivo (reactive oxygen species (ROS) analysis. For Western blots, a modified t-test was used to compare the experimental groups with the normalized control ratio, and to evaluate among the experimental groups. A value of P < 0.05 was taken to indicate statistical significance.
Results
Effect of BCNI and Colforsin on Body Weight and Blood Pressure
There were no group differences in body weight 
Effect of BCNI and Colforsin on Erectile Function
Erectile function was decreased in the BCNI group, as evident by decreased total ICP/MAP and maximum ICP/MAP (P < 0.05) at both voltages relative to sham rats ( Fig. 1) . Treatment with colforsin augmented (P < 0.05) total ICP/ MAP and maximum ICP/MAP at both voltages in BCNI rats. Erectile function in sham rats was not affected by colforsin treatment.
Effect of BCNI and Colforsin on nNOS Phosphorylation (Ser-1412 and Ser-847) and Total nNOS Protein Expression in the Penis and MPG
After BCNI, nNOS phosphorylation on Ser-1412 (positive regulatory site) was increased (P < 0.05) in the penis ( Fig. 2A) and MPG (Fig. 2B) . Treatment of BCNI rats with colforsin decreased (P < 0.05) nNOS phosphorylation on Ser-1412 in the penis, but not in the MPG. In sham rats, colforsin treatment had no effect in the penis, although it increased (P < 0.05) nNOS phosphorylation on Ser-1412 in the MPG.
After BCNI, nNOS phosphorylation on Ser-847 (negative regulatory site) was increased (P < 0.05) in the penis (Fig. 2C) and MPG (Fig. 2D) . Treatment of BCNI rats with colforsin decreased (P < 0.05) nNOS phosphorylation on Ser-847 in the penis but not in the MPG. Colforsin treatment did not affect nNOS phosphorylation on Ser-847 in the penis or MPG in sham rats.
Protein expression of total nNOS was decreased (P < 0.05) in the penis but not in the MPG after BCNI, and was unaffected by colforsin treatment in both tissues (Fig. 3A,B) .
Effect of BCNI and Colforsin on nNOS Uncoupling in the Penis and MPG and on Binding of PIN to nNOS in the Penis
The ratio of nNOS dimers (functional nNOS)/monomers (non-functional nNOS) was decreased (P < 0.05) in the penis (Fig. 4A) and MPG (Fig. 4B) after BCNI. Colforsin treatment of BCNI rats increased significantly (P < 0.05) the dimer/ monomer ratio to sham levels in both the penis and MPG. Because increased binding of PIN to nNOS has been implicated in nNOS uncoupling, we next measured binding of PIN to nNOS using partially purified penile samples, thus allowing the detection of nNOS and proteins bound to nNOS using specific antibodies [30, 31, 37] . Binding of PIN to nNOS was increased (P < 0.05) in the penis of the BCNI group and normalized (P < 0.05) by colforsin (Fig. 4C) . We did not evaluate binding of PIN to nNOS in the MPG because this evaluation is not feasible given the limited tissue amount of the MPG. . 5B) were increased (P < 0.05) in the penis after BCNI. Colforsin treatment of BCNI rats decreased H 2 O 2 and total ROS production in the penis to levels which were not different from those in sham rats. Superoxide (O 2 -) production showed a trend (P = 0.15) towards increase by BCNI and a trend (P = 0.13) towards decrease after colforsin treatment in the penis of the BCNI group (Fig. 5C ). ROS production in the penis was not affected by colforsin treatment in sham rats. We did not evaluate ROS production in the MPG because this evaluation was not feasible given the size of the MPG; however, protein expression of gp91 phox was increased (P < 0.05) in the MPG of BCNI rats and was normalized (P < 0.05) by colforsin treatment (Fig. 5D ). Protein expression of gp91 phox in the penis was not affected by BCNI (data not shown).
Effect of BCNI on Protein Expression of Active Caspase 3 in the MPG
Protein expression of active caspase 3, an apoptotic marker, was increased (P < 0.05) in the MPG after BCNI. Colforsin treatment of BCNI rats resulted in a protein expression level of active caspase 3, which was not different from values in (Fig. 6A ). Because previous studies had shown increased protein expression of caspase 3 and apoptosis in the penis of cavernous injury models as early as 3 days postinjury, we did not evaluate caspase 3 expression in the penis [5, 38, 39] .
Effect of Colforsin on Protein Expression of PKA-Ca Subunit in the Penis
Because cAMP-induced activation of PKA is associated with increased protein expression of PKA-Ca subunit, we measured the expression of this protein in the penis [40, 41] . It was decreased (P < 0.05) in the BCNI rats and normalized (P < 0.05) by colforsin treatment (Fig. 6B) . We did not evaluate PKA-Ca expression in the MPG because this evaluation is not feasible given the limited amount of MPG tissue.
Discussion
The present study shows that PKA activation reverses aberrant nNOS signalling and oxidative stress in the neuropathic penis, which is associated with neurogenic ED in vivo. The molecular mechanism underlying the reduction in nNOS bioactivity after CN injury involves nNOS phosphorylation, nNOS uncoupling, and elevated free radical production. We found that the PKA activator colforsin protects normal nNOS signalling in the penis from neuropathy and neuroregulated erectile function via preservation of nNOS phosphorylation and nNOS coupled function and abrogation of free radical level production in the penis and its local neural supply. Collectively, we showed that nNOS post-translational regulation is involved in erectile tissue integrity in the face of neuropathy.
nNOS phosphorylation is one of the major mechanisms regulating nNOS bioactivity [19, 42] . nNOS activation by [42, 43] . Phosphorylation of nNOS on Ser-1412 activates the enzyme, while phosphorylation of nNOS on Ser-847 inhibits the enzyme. nNOS phosphorylation on Ser-1412 activates the enzyme's catalytic function by reducing the enzyme's calcium requirement and facilitating electron transfer [44] . Phosphorylation of nNOS at Ser-847 reduces its activity by inhibiting calcium-CaM binding [45] . We have recently demonstrated a major role for PKA-mediated phosphorylation of nNOS (Ser-1412) in mediating penile erection [19] . In the present study, we confirmed this finding by showing that the PKA activator colforsin induced an increase in P-nNOS (Ser-1412) in the MPG of healthy, shamoperated rats. Conversely, phosphorylation of nNOS on this site was increased in both penis and penile innervation after CN injury. Increased P-nNOS (Ser-1412) conceivably indicates a deleterious effect of over-activated nNOS in the neuropathic penis and penile innervation. Previous studies showed that over-activation of kinases, such as Akt, by excessive NO may lead to excessive nNOS phosphorylation on Ser-1412 [45, 46] . It is well documented that neuronal insults such as brain ischaemia cause overproduction of NO, allowing its conversion into peroxynitrite, which can cause neuronal cell death [47] . While Akt activation in the penis and penile innervation is not associated with physiological penile erection, it is possible that this pathway becomes activated in pathophysiological settings such as nerve damage, causing excessive nNOS phosphorylation on Ser-1412 [19] .
Colforsin possibly inhibits Akt activation thus preventing excessive nNOS phosphorylation in the penis and associated penile neuropathy. In support of this hypothesis, previous in vitro studies demonstrated that cAMP-dependent signalling inhibits Akt activity by blocking the coupling between Akt and its upstream regulators, phosphoinositide-dependent kinase (PDK) and phosphatidylinositol 3-kinase (PI3K), in the plasma membrane [48, 49] .
Additionally, we showed the involvement of the inhibitory nNOS phosphorylation site (Ser-847) in ED after BCNI. The phosphorylation of nNOS on this inhibitory site was increased in both the penis and MPG by CN injury, conceivably rendering nNOS less active. Colforsin decreased phosphorylation of this site on nNOS, conceivably recovering physiological neuronal NO catalysis. While the exact mechanism of this action of colforsin in the penis and penile innervation is not known, it is possible that PKA-dependent activation of protein phosphatase 1/PP2 dephosphorylates nNOS on this site and activates it, as shown previously in hypothalamic neurons [50] . Collectively, our findings demonstrate the physiological significance of nNOS posttranslational modification by phosphorylation in vivo in the preservation of neuroregulated erectile function.
Total nNOS expression in the penis, but not the MPG, was decreased after BCNI, consistent with prior findings by us and others [11, 12, 14, 15] . A previous study described that CN injury decreased nNOS+ nerve fibres in the CN distal from the site of nerve crush, but not in the MPG [14] . Decreased expression of nNOS indicates deterioration of nitrergic neurons in the penis and neurogenic ED after CN injury. The lack of effect of colforsin treatment on total nNOS expression in the present study is conceivably attributable to the short duration of treatment without the influence of regenerated nNOS+ nerve fibres.
An important mechanism of decreased NO bioavailability is functional uncoupling of NOS, characterized by the diversion of electron transfer within the enzyme from L-arginine oxidation. This molecular event reduces molecular oxygen to form superoxide instead of NO [22] . Several mechanisms of nNOS uncoupling have been described, such as limited availability of the cofactor tetrahydrobiopterin (BH 4 ), the substrate L-arginine, phosphorylation of nNOS at Ser-847, and increased binding of PIN to nNOS [51] [52] [53] [54] . Increased nNOS uncoupling in both the penis and MPG was evident after BCNI, as demonstrated by a decreased dimer/monomer ratio. The precise mechanism by which nNOS becomes uncoupled under conditions of penile neuropathy and nerve degeneration is unclear at this time but may be related to increased nNOS phosphorylation on Ser-847 and increased binding of PIN to nNOS. While the mechanism underlying increased nNOS uncoupling by nNOS phosphorylation at Ser-847 is not known, PIN, by occupying the calciumcalmodulin site on nNOS, destabilizes the dimeric form of nNOS and decreases the enzyme's activity [5, 39] . Previous studies showed ED in rats with local injection of PIN cDNA, which may be explained by PIN-induced nNOS uncoupling [55, 56] . Furthermore, we previously reported that genetic or pharmacological inhibition of dysfunctional nNOS afforded erectile function preservation after BCNI, suggesting that aberrant nNOS signalling is detrimental for erectile function after penile neuropathy, which is in line with our current findings that overactivated, but uncoupled, dysfunctional nNOS reduces erectile function after BCNI [57] . Recently, nNOS uncoupling has been described in the MPG of rats 14 days after BCNI [7] . We extend this finding and suggest a role for nNOS uncoupling both in the penis and MPG in ED pathophysiology in the CN injury model. Importantly, our findings implicate the binding of PIN to nNOS and nNOS phosphorylation on Ser-847 as potentially important mediators of nNOS uncoupling resulting in neurogenic ED.
Uncoupled nNOS possibly contributes to decreased NO bioavailability and increased ROS formation by the enzyme, conditions which are both apparent in the neuropathic penis and MPG after BCNI [45, 58] . In the present study, we directly measured superoxide and H 2 O 2 produced in erectile tissue, demonstrating increased levels of these free radicals after BCNI. Superoxide is a highly reactive molecule with well documented adverse effects on neurovascular function, such as quenching of NO, induction of apoptosis, increased endothelial cell permeability, and promotion of neurodegeneration [59, 60] signalling cascades, including apoptosis, angiogenesis, promotion of endothelial barrier dysfunction, and induction of inflammatory proteins [61] . In addition, we demonstrated an upregulation of the NADPH oxidase subunit gp91 phox in the MPG after BCNI, indicating NADPH oxidase as another source of oxidative stress in the MPG. Upregulation of active caspase 3 in the MPG after BCNI suggests that apoptosis takes place in penile innervation, possibly further contributing to deterioration of nitrergic neurons and ED. Colforsin prevented an increase in free radicals in the penis, and it prevented upregulation of gp91 phox and active caspase 3 in the MPG in response to CN injury. PKA stimulation has previously been shown to attenuate superoxide production and NADPH oxidase activity in hypothalamic neuronal and vascular smooth muscle cells [62, 63] . Furthermore, PKA stimulation has been found to prevent H 2 O 2 -induced apoptosis and caspase-3 activation and H 2 O 2 -induced endothelial cell senescence [64, 65] . PKA is also involved in ROS detoxification, as PKA stimulation has been shown to activate several cellular antioxidants, including SOD1, SOD2, SOD3, catalase, peroxyredoxin 2, glutathione peroxidase 1, heme oxygenase-1, and NADPH quinone oxidoreductase (NQO1) [62, [64] [65] [66] . In this context, colforsin could have suppressed ROS production and/or enhanced ROS detoxification capacity, ultimately resulting in suppression of ROS detected in erectile tissue post-BCNI.
Colforsin is a water-soluble forskolin derivative and adenylate cyclase activator, which increases intracellular cAMP levels with subsequent activation of PKA signalling [67] . The neuroprotective and neurorestorative effects of cAMP have been described in several animal models of peripheral nervous system injury and are thus consistent with our results. In animal models of peripheral nerve injury cAMP, acting through PKA-dependent and PKA-independent mechanisms, transcriptionally activates a series of downstream effectors within injured neurons and Schwann cells to promote neuronal survival and regeneration [68] . Furthermore, cAMP-mediated pathways include inhibition of phosphodiesterase type 5 and modulation of collagen/smooth muscle synthesis in cultured human corpus cavernosum smooth muscle cells, and relaxation of mouse corpus cavernosum in the absence of functional NO signalling [69] [70] [71] . The protective effect of colforsin in our animal model could be attributable to upregulation of PKA-Ca subunits. Inactive PKA holoenzyme is a heterotetramer composed of two types of subunits: regulatory (R) subunits and catalytic (C) subunits [72] . In the presence of increased cAMP by colforsin, the holoenzyme becomes active by binding two cAMP molecules cooperatively to each R subunit, resulting in a conformational change, thus releasing the two C subunits to phosphorylate downstream targets [43, 44] . The summary of BCNI and colforsin on nNOS signalling and oxidative stress in penile innervation is shown in Fig. 7 . These findings may partially explain previous observations in humans that penile exercise post-RP may improve erectile function possibly as a result of increase in oxygen-dependent cAMP generation during erect state [73, 74] .
We acknowledge that the use of PKA inhibitors with opposite effects to those of colforsin in vivo would substantiate our conclusion that PKA activation preserves nNOS signalling in the neuropathic penis. Future studies are needed to establish which neuroprotective downstream signalling factors and targets of cAMP, other than nNOS itself, may be induced by colforsin in injured CN nerves and accompanying Schwann cells. Furthermore, for the present study we performed colforsin treatment at a single dose just before BCNI to test its acute effect on nNOS signalling. Future studies evaluating dose-response and colforsin treatment given at different time points before and after BCNI may determine the maximum protection on nNOS signalling and the possible neurorestorative potential of PKA activation in the penile innervation.
In summary, the present study shows that, in the context of penile neuropathy, nNOS bioactivity is altered via nNOS posttranslational modification and nNOS uncoupling resulting in ED, PKA activation by colforsin promotes nNOS bioactivity and counteracts neuropathic oxidative stress in the penis and penile innervation, thereby preserving erectile function.
